medigraphic.com
ISSN 1561-302X (Print)

2021, Number 2

<< Back Next >>

Rev cubana med 2021; 60 (2)

Mortality of chronic kidney patients of working ages in Cuba

Marín PMC, Gutiérrez GF, Martínez MMÁ, Rodríguez GCA, Dávalos IJM

Language: Spanish
References: 41
Page: 1-10
PDF size: 324.55 Kb.


ABSTRACT

Introduction: Chronic kidney disease constitutes a major health problem in Cuba and worldwide. By 2040 it may become the fifth most common cause of years of life potentially lost, worldwide, and a major cause of health expenses, economy and social security.
Objective: To describe mortality in chronic kidney patients of working ages in Cuba, from 2011to 2017, according to selected sociodemographic variables.
Methods: This is descriptive cross-sectional research. The universe consisted of 5,716 deceased subjects with chronic kidney disease. The information was taken from the mortality databases of the National Directorate of Statistics, from the Ministry of Public Health. The variables were studied age, sex, occupation and main causes of death. Gross and specific mortality rates were calculated.
Results: In working age, mortality from chronic kidney disease fluctuated from 2011 to 2017. The mean age at death was 53.7 years, those over 61 years of age, men, had the highest risk (16 per 10,000 inhabitants). The rate in the economically active unemployed population was 33 per 10,000 inhabitants. The risk was higher in basic occupations (9 per 10,000 inhabitants). Hypertensive kidney disease was the leading cause of death (17 per 100,000 population).
Conclusions: There is a slight increase in mortality, the risk is higher in men, the highest rate is in the economically active unemployed population and in basic occupations. The leading cause of death is hypertensive kidney disease.


REFERENCES

  1. Álvarez Estévez G, García Trabanino R, Valdés Miranda R, Pérez-Oliva Díaz J, Silva Julio E, Sánchez-Polo V. Declaración de Panamá: contribuyendo a reducir la mortalidad en hemodiálisis en Centroamérica y el Caribe. Nefro Latinoam. 2019;16:10-12. https://doi.org//10.24875/NEFRO.18000049

  2. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052-90. https://doi.org//10.1016/S0140-6736(18)31694-5

  3. Essue BM, Laba M., Knaul F. Economic Burden of Chronic Ill Health and Injuries for Households in Low- and Middle-Income Countries. In: Jamison DT, Gelband H, Horton S, et al., editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2017 Nov 27. Chapter 6. https://doi.org//10.1596/978-1-4648-0527-1_ch6

  4. Otero A, de FA, Gayoso P, Garcia F: Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia. 2010;30(1):78-86.

  5. Carrillo-Larco RM, Bernabé-Ortiz A. Mortalidad por enfermedad renal crónica en el Perú: tendencias nacionales 2003-2015, Revista Peruana de Medicina Experimental y Salud Publica. 2018;35(3). http://dx.doi.org/10.17843/rpmesp.2018.353.3633

  6. Rodríguez Hernández JM, González Nájera R, Albavera Hernández C. Comportamiento de la mortalidad por enfermedad renal crónica hipertensiva en la República Mexicana entre 1998-2009. Un problema creciente Cendex, Pontificia Universidad Javeriana, Colombia, Instituto Mexicano del Seguro Social, Instituto Nacional de Salud Pública, México 149:152-60 artículo original Gaceta Médica de México. 2013;149-52.

  7. Jayasumana MACS, Paranagama PA, Amarasinghe MD, Wijewardane KMRC, Dahanayake KS, Fonseka SI, et al. Possible link of chronic arsenic toxicity with Chronic Kidney Disease of unknown etiology in Sri Lanka. J Nat Sci Res. 2013[acceso: 03/09/2016];3(1):64-73. Disponible en: http://www.iiste.org/Journals/index.php/JNSR/article/view/4193

  8. Abraham G, Varughese S, Thandavan T, Iyengar A, Fernando E, Naqvi SA, et al. Chronic kidney disease hotspots in developing countries in South Asia. Clin Kidney J. 2016;9(1):135-41.

  9. Jayasumana C, Orantes C, Herrera R, Almaguer M, Lopez L, Silva L, et al. Chronic interstitial nephritis in agricultural communities: a worldwide epidemic with social, occupational and environmental determinants. Nephrol Dial Transplant. 2016[acceso: 14/11/2016] pii: gfw346. [Epub ahead of print].

  10. García-Trabanino R, Jarquín E, Wesseling C, Johnson RJ, González-Quiroz M, Weiss I, et al. Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador-A cross-shift study of workers at risk of Mesoamerican nephropathy. Environ Res. 2015;142:746-55.

  11. Ramírez-Rubio O, Amador JJ, Kaufman JS, Weiner DE, Parikh CR, Khan U, et al. Urine biomarkers of kidney injury among adolescents in Nicaragua, a region affected by an epidemic of chronic kidney disease of unknown aetiology. Nephrol DialTransplant. 2016;31(3):424-33.

  12. El Salvador National Institute of Health. Declaración de San Salvador-Abordaje integral de la enfermedad renal túbulo-intersticial crónica de Centroamérica (ERTCC) que afecta predominantemente a las comunidades agrícolas. San Salvador: Ministry of Public Health and Social Asístanse of El Salvador; 2013.

  13. International Society of Nephrology 2019. United Nations High Level Meeting on UHC: Moving Together to Build Kidney Health worldwide; 2019[acceso: 20/07/2019]. Disponible en: https://www.theisn.org/images/Advocacy_4_pager_2019_Final_WEB_pagebypage. pdf

  14. Anuarios Estadísticos de salud. Cuba. Año del 2011-2017. 2018 [acceso: 20/07/2019]. Disponible en: http://bvscuba.sld.cu/anuario-estadistico-de-cuba/le

  15. Oficina Nacional de Estadísticas e Información. Clasificador Nacional de Actividades Económicas (CNAE). 2020[acceso: 18/02/2021]. Disponible en: http://www.onei.gob.cu/publicaciones-tipo/Anuario

  16. Clasificación Internacional de Enfermedades. Med Ciclopedia. 21. Caídas y accidentes diversos W00-X59. 1992[acceso: 09/07/2016]. Disponible en: Disponible en: http://www.iqb.es/patologia/e20_015.htm

  17. Chan M. La OPS/OMS y la Sociedad Latinoamericana de Nefrología llaman a prevenir la enfermedad renal. 2015[acceso: 19/02/2021]. Disponible en: http://www.paho.org

  18. Jódar E. Corazón y riñón, implicados en la diabetes tipo 2. Méd Hospitalario. 2018[acceso: 19/02/2021]. Disponible en: Disponible en: http://www.immedicohospitalario.es›noticia›corazon-y-rin

  19. Julián-Mauro JC, Molinuevo-Tobalina JÁ, Sánchez-González JC. La situación laboral del paciente con enfermedad renal crónica en función del tratamiento sustitutivo renal. Nefrología 2012;32(4):439-45. https://doi.org//10.3265/Nefrologia.pre2012.Apr.11366

  20. O'Donnell JK, Tobey M, Weiner DE, Stevens LA, Johnson S, Stringham P, et al. Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol Dial Transplant. 2011;26(9):2798-805.

  21. Ramírez Rubio O, Kangsen Scammell M, Amador JJ, Brooks D, Kaufman J, Weiner D. Enfermedad Renal Crónica en Nicaragua: análisis cualitativo de entrevistas semiestructuradas con médicos y farmacéuticos. 2011[acceso: 09/07/2016]. Disponible en: Disponible en: http://www.cao-ombudsman.org

  22. Concepción-Zavaleta M, Cortegana-Aranda J, Ocampo-Rujel N, Gutiérrez-Portilla W. Factores de riesgo asociados a mortalidad en pacientes con enfermedad renal crónica terminal. Rev Soc Peru Med Interna. 2015[acceso: 09/07/2016];28(2):72-8. Disponible en: Disponible en: http://www.medicinainterna.net.pe›2015›articulo_original2

  23. Ávila C, Bright R, Gutiérrez JC, Hoadley K, Manuel C, Romero N, et al. Guatemala, Análisis del Sistema de Salud 2015. Bethesda, MD: Proyecto Health Finance and Governance. Abt Associates Inc. 2015[acceso: 19/02/2021]. Disponible en: Disponible en: http://www.epidemiologia.mspas.gob.gt/

  24. Lopera-Medina MM. La enfermedad renal crónica en Colombia: necesidades en salud y respuesta del Sistema General de Seguridad Social en Salud. Rev. Gerenc. Polít. Salud. 2016;15(30): 212-33. http://dx.doi.org/10.11144/Javeriana.rgyps15-30.ercc

  25. Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández CE, Bayarre H, et al. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009. MEDICC Rev. 2011[acceso: 19/02/2021];13(4):14-22. Disponible en: Disponible en: http://www.medigraphic.com›cgi-bin

  26. Pérez-Oliva Díaz JF, Almaguer López M, Herrera Valdés R, Martínez Machín M, Martínez Morales M. Registry of Chronic Kidney Disease in Primary Health Care in Cuba, 2017. Rev haban cienc méd. 2018[citado: 19/02/2021];17(6):1009-21. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2018000601009&lng=es

  27. Dorling D. Unemployment and health. BMJ. 2009. https://doi.org/10.1136/bmj.b829

  28. López Nistal LM, Gran Álvarez MA, Martinez López Ld. Mortalidad de los cubanos en edad laboral según sexo. Rev Cubana Salud Pública. 2014[acceso: 19/02/2021];40(1). Disponible en: Disponible en: http://www.revsaludpublica.sld.cu/index.php/spu/article/view/28

  29. Vázquez MI. Aspectos Psicosociales del Paciente en Diálisis. En: Lorenzo V, López Gómez JM (Eds). Nefrología al día. Aspectos Psicosociales del Enfermo renal. 2016[citado: 19/02/2021]. Disponible en: Disponible en: https://www.nefrologiaaldia.org/276

  30. Hurtado-Arestegui A, Plata-Cornejo R, Cornejo A, Mas G, Carbajal L, Sharma S, et al. Higher prevalence of unrecognized kidney disease at high altitude. J Nephrol. 2018;31(2):263-9.

  31. Wegman DH, Apelqvist J, Bottai M, Ekstrom U, Garcia-Trabanino R, Glaser J, et al. Intervention to diminish dehydration and kidney damage among sugarcane workers. Scand J Work Environ Health 2018;44(1):16-24.

  32. Valcke M, Levasseur ME, Soares da Silva A, Wesseling C. Pesticide exposures and chronic kidney disease of unknown etiology: an epidemiologic review. Environ Health. 2017;16(1):49.

  33. Ghosh R, Siddarth M, Singh N, Tyagi V, Kare PK, Banerjee BD, et al. Organochlorine pesticide level in patients with chronic kidney disease of unknown etiology and its association with renal function. Environ Health Prev Med. 2017;22(1):49.

  34. Yang CW. Leptospirosis Renal Disease: Emerging Culprit of Chronic Kidney Disease Unknown Etiology. Nephron. 2018;138(2):129-36.

  35. Pérez-Oliva Díaz JF, Almaguer López M, Herrera Valdés R, Martínez Machín M, Martínez Morales M. Registro de la Enfermedad Renal Diabética en la Atención Primaria de Salud. 2015. Rev haban cienc méd. 2017[acceso: 19/02/2021];16(4). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/2119

  36. Reque J, Garcia-Prieto A, Linares T, Vega A, Abad S, Panizo N, et al. Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients. Am J Nephrol. 2017;45(2):107-14.

  37. Harel Z, Chertow GM, Shah PS, Harel S, Dorian P, Yan AT, et al. Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis. Can J Cardiol. 2017;33(6):737-46. https://doi.org/10.1016/j.cjca.2017.02.004

  38. Williams R. International Diabetes Federation Atlas. Novena edición. 2019[acceso: 19/11/2019]. Disponible en: http://www.internationaldiabetresfederation

  39. Birabaharan M, Strunk A, Garg A, Hagmann S. Prevalence of tyope 2 diabetes mellitus among patients living with HIV in the United States. Infectious Disease. 2019[acceso: 19/02/2021]. Disponible en: http://www.infectiousdiseaseadvisor.com

  40. Gregg EW, Cheng YJ, Srinivasan M, Lin J, Geiss LS, Albright AL, Imperatore G. Trends in causespecific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet. 2018;391(10138):2430-40. https://doi.org//10.1016/S0140-6736(18)30314-3

  41. Perelló Martínez J, Martín Romero A, Erraez Guerrero S. Marcapasos y Morbi-Mortalidad en pacientes con Enfermedad Renal Crónica. Resúmenes del XLVIII Congreso Nacional de la Sociedad Española de Nefrología. 2018. https://doi.org/10.3265/Nefrologia.pre2018.Nov.n38.vS1




2020     |     www.medigraphic.com